Scarica l'app Stockscreener
2.02
11.01%
-0.25
Dopo l'orario di chiusura:
1.85
-0.17
-8.42%
Precedente Chiudi:
$2.27
Aprire:
$1.95
Volume 24 ore:
6.38M
Relative Volume:
0.39
Capitalizzazione di mercato:
$95.13M
Reddito:
$1.20M
Utile/perdita netta:
$-52.41M
Rapporto P/E:
-2.2198
EPS:
-0.91
Flusso di cassa netto:
$-31.25M
1 W Prestazione:
-8.18%
1M Prestazione:
+304.24%
6M Prestazione:
+141.05%
1 anno Prestazione:
-19.52%
Intervallo 1D:
$1.83
$2.07
Intervallo di 1 settimana:
$1.83
$2.63
Portata 52W:
$0.387
$3.87
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Nome
Rani Therapeutics Holdings Inc
Settore
Industria
Telefono
(408) 457-3700
Indirizzo
2051 RINGWOOD AVENUE, SAN JOSE
Confronta RANI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
2.02 | 221.42M | 1.20M | -52.41M | -31.25M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-02 | Iniziato | Oppenheimer | Outperform |
| 2024-06-14 | Iniziato | Maxim Group | Buy |
| 2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
| 2023-04-17 | Ripresa | BTIG Research | Buy |
| 2022-10-11 | Iniziato | UBS | Buy |
| 2022-07-27 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-13 | Iniziato | Wedbush | Outperform |
Mostra tutto
Rani Therapeutics Holdings Inc Borsa (RANI) Ultime notizie
How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis tools2025 Big Picture & Breakout Confirmation Trade Signals - newser.com
How high can Rani Therapeutics Holdings Inc. stock go2025 Historical Comparison & Weekly Top Gainers Trade List - newser.com
Will Rani Therapeutics Holdings Inc. stock attract more institutional investorsTake Profit & Consistent Growth Equity Picks - newser.com
Rani Therapeutics Secures Funding And A Billion-Dollar Pharma Deal - Finimize
Rani Therapeutics announces $1.085 billion Chugai collaboration By Investing.com - Investing.com Canada
Will Rani Therapeutics Holdings Inc. bounce back from current support2025 Volume Leaders & Safe Capital Growth Trade Ideas - newser.com
Rani Therapeutics Reports Financial Challenges Amid Innovation - TipRanks
Rani Therapeutics Q3 net loss decreases, extends cash runway into 2028 - MarketScreener
Rani Therapeutics Holdings, Inc. SEC 10-Q Report - TradingView
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update - The Manila Times
Rani (NASDAQ: RANI) expects runway into 2028, announces up to $1.085B Chugai pact - Stock Titan
How Rani Therapeutics Holdings Inc. stock benefits from global expansionQuarterly Profit Report & Community Verified Trade Signals - fcp.pa.gov.br
Short interest data insights for Rani Therapeutics Holdings Inc.Rate Hike & Reliable Price Breakout Signals - newser.com
Is Rani Therapeutics Holdings Inc. stock trading at a premium valuation2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Can Rani Therapeutics Holdings Inc. stock maintain growth trajectoryJuly 2025 Decliners & Target Return Focused Picks - newser.com
Technical analysis overview for Rani Therapeutics Holdings Inc. stockPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com
Institutional scanner results for Rani Therapeutics Holdings Inc.July 2025 Market Mood & Low Risk Investment Opportunities - newser.com
Can momentum traders help lift Rani Therapeutics Holdings Inc.Portfolio Risk Report & Weekly Consistent Profit Watchlists - newser.com
How Rani Therapeutics Holdings Inc. stock compares to industry benchmarksJuly 2025 Trends & Capital Efficiency Focused Strategies - fcp.pa.gov.br
Rani Therapeutics: Oral Biologics Vision Still Has Early-Stage Risks (NASDAQ:RANI) - Seeking Alpha
Rani Therapeutics Target of Unusually High Options Trading (NASDAQ:RANI) - MarketBeat
Multi asset correlation models including Rani Therapeutics Holdings Inc.July 2025 Institutional & Verified Swing Trading Watchlist - newser.com
Will Rani Therapeutics Holdings Inc. stock reach all time highs in 2025 - newser.com
Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthPortfolio Risk Summary & High Yield Equity Trading Tips - newser.com
Rani Therapeutics’ Share Price Surges Following Chugai Partnership - timothysykes.com
MSN Money - MSN
Why retail investors pile into Rani Therapeutics Holdings Inc. stock2025 Sector Review & Expert Verified Stock Movement Alerts - fcp.pa.gov.br
Rani Therapeutics: Underdog to Top Performer? - StocksToTrade
Is Rani Therapeutics Holdings Inc. stock supported by innovation pipelineQuarterly Portfolio Review & Consistent Growth Equity Picks - newser.com
Rani Therapeutics Holdings Inc Azioni (RANI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.44%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):